Suppr超能文献

氯化锌对干扰素抑制人肝癌 Huh7 细胞甲型肝炎病毒复制的增效作用。

Additive Effects of Zinc Chloride on the Suppression of Hepatitis A Virus Replication by Interferon in Human Hepatoma Huh7 Cells.

机构信息

Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan

Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.

出版信息

In Vivo. 2020 Nov-Dec;34(6):3301-3308. doi: 10.21873/invivo.12168.

Abstract

BACKGROUND/AIM: Hepatitis A virus (HAV) infection is still one of the serious health problems worldwide, despite the existence of effective vaccines for HAV. Zinc compounds have antiviral activities against various DNA and RNA viruses. Therefore, we investigated the effects of zinc compounds on the antiviral activity of interferon against HAV.

MATERIALS AND METHODS

The effects of zinc compounds with or without interferon on HAV genotype IIIA HA11-1299 replication were examined in human hepatoma Huh7 cells. Cell viability was examined by the MTS assay. Inflammasome associated gene expression was examined by real-time reverse transcription-polymerase chain reaction.

RESULTS

Both zinc sulfate and zinc chloride had an inhibitory effect on HAV replication. Zinc sulfate tended to enhance while zinc chloride significantly enhanced the anti-HAV effect induced by interferon-alpha-2a. Zinc chloride significantly up-regulated mitogen-activated protein kinase 12 (MAPK12) and down-regulated 6 related genes [baculoviral IAP repeat containing 3 (BIRC3), interleukin 1 beta (IL1B), proline-serine-threonine phosphatase interacting protein 1 (PSTPIP1), prostaglandin-endoperoxide synthase 2 (PTGS2), PYD and CARD domain containing (PYCARD), and tumor necrosis factor (TNF)].

CONCLUSION

Zinc chloride inhibits HAV replication and has additive effects on the anti-HAV activities of interferon.

摘要

背景/目的:尽管存在针对甲型肝炎病毒(HAV)的有效疫苗,但 HAV 感染仍是全球严重的健康问题之一。锌化合物对多种 DNA 和 RNA 病毒具有抗病毒活性。因此,我们研究了锌化合物对干扰素抗 HAV 活性的影响。

材料与方法

在人肝癌细胞 Huh7 中,检测锌化合物与干扰素联合或不联合对 HAV 基因型 IIIA HA11-1299 复制的影响。通过 MTS 检测法检测细胞活力。通过实时逆转录-聚合酶链反应检测炎症小体相关基因的表达。

结果

硫酸锌和氯化锌均对 HAV 复制具有抑制作用。硫酸锌有增强干扰素-α-2a 抗 HAV 作用的趋势,而氯化锌则显著增强。氯化锌显著上调丝裂原活化蛋白激酶 12(MAPK12)并下调 6 个相关基因[杆状病毒 IAP 重复序列包含 3(BIRC3)、白细胞介素 1β(IL1B)、脯氨酸-丝氨酸-苏氨酸磷酸酶相互作用蛋白 1(PSTPIP1)、前列腺素内过氧化物合酶 2(PTGS2)、PYD 和 CARD 结构域包含蛋白(PYCARD)和肿瘤坏死因子(TNF)]。

结论

氯化锌抑制 HAV 复制,并与干扰素的抗 HAV 活性具有相加作用。

相似文献

3
Evaluation of Potential Anti-Hepatitis A Virus 3C Protease Inhibitors Using Molecular Docking.
Int J Mol Sci. 2022 May 27;23(11):6044. doi: 10.3390/ijms23116044.
4
The JAK2 inhibitor AZD1480 inhibits hepatitis A virus replication in Huh7 cells.
Biochem Biophys Res Commun. 2015 Mar 20;458(4):908-12. doi: 10.1016/j.bbrc.2015.02.058. Epub 2015 Feb 19.
5
Favipiravir Inhibits Hepatitis A Virus Infection in Human Hepatocytes.
Int J Mol Sci. 2022 Feb 27;23(5):2631. doi: 10.3390/ijms23052631.
6
Amantadine and Rimantadine Inhibit Hepatitis A Virus Replication through the Induction of Autophagy.
J Virol. 2022 Sep 28;96(18):e0064622. doi: 10.1128/jvi.00646-22. Epub 2022 Aug 30.
7
Sofosbuvir inhibits hepatitis A virus replication in vitro assessed by a cell-based fluorescent reporter system.
Antiviral Res. 2018 Jun;154:51-57. doi: 10.1016/j.antiviral.2018.04.007. Epub 2018 Apr 10.
8
The ZCCHC14/TENT4 complex is required for hepatitis A virus RNA synthesis.
Proc Natl Acad Sci U S A. 2022 Jul 12;119(28):e2204511119. doi: 10.1073/pnas.2204511119. Epub 2022 Jul 7.

引用本文的文献

1
Recent Advances in mRNA-Based Vaccines Against Several Hepatitis Viruses.
Biol Proced Online. 2025 Jun 3;27(1):20. doi: 10.1186/s12575-025-00269-2.
2
Antiviral activity of zinc against hepatitis viruses: current status and future prospects.
Front Microbiol. 2023 Oct 16;14:1218654. doi: 10.3389/fmicb.2023.1218654. eCollection 2023.
3
Muscle Cramps in Outpatients with Liver Diseases in Tokyo, Japan.
Medicina (Kaunas). 2023 Aug 22;59(9):1506. doi: 10.3390/medicina59091506.
4
Treatment Options for Hepatitis A and E: A Non-Systematic Review.
Viruses. 2023 Apr 28;15(5):1080. doi: 10.3390/v15051080.
5
Hepatitis A: Viral Structure, Classification, Life Cycle, Clinical Symptoms, Diagnosis Error, and Vaccination.
Can J Infect Dis Med Microbiol. 2023 Jan 4;2023:4263309. doi: 10.1155/2023/4263309. eCollection 2023.
6
Hepatitis A Virus Infection and Molecular Research.
Int J Mol Sci. 2022 Jun 29;23(13):7214. doi: 10.3390/ijms23137214.
7
Suppressors of Cytokine Signaling and Hepatocellular Carcinoma.
Cancers (Basel). 2022 May 22;14(10):2549. doi: 10.3390/cancers14102549.

本文引用的文献

1
Co-Occurrence of Hepatitis A Infection and Chronic Liver Disease.
Int J Mol Sci. 2020 Sep 2;21(17):6384. doi: 10.3390/ijms21176384.
3
Gangliosides are essential endosomal receptors for quasi-enveloped and naked hepatitis A virus.
Nat Microbiol. 2020 Sep;5(9):1069-1078. doi: 10.1038/s41564-020-0727-8. Epub 2020 May 25.
4
Cell Culture Systems and Drug Targets for Hepatitis A Virus Infection.
Viruses. 2020 May 12;12(5):533. doi: 10.3390/v12050533.
5
Hepatitis A: Epidemiology, Natural History, Unusual Clinical Manifestations, and Prevention.
Gastroenterol Clin North Am. 2020 Jun;49(2):191-199. doi: 10.1016/j.gtc.2020.01.002. Epub 2020 Mar 29.
6
ZBED2 is an antagonist of interferon regulatory factor 1 and modifies cell identity in pancreatic cancer.
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11471-11482. doi: 10.1073/pnas.1921484117. Epub 2020 May 8.
7
A novel, bedside, etiology specific prognostic model (Peds-HAV) in hepatitis A induced pediatric acute liver failure.
Hepatol Int. 2020 Jul;14(4):483-490. doi: 10.1007/s12072-020-10050-0. Epub 2020 May 5.
8
Hepatitis A Virus in Lao People's Democratic Republic: Seroprevalence and Risk Factors.
Am J Trop Med Hyg. 2020 Jul;103(1):164-168. doi: 10.4269/ajtmh.19-0451. Epub 2020 Apr 23.
10
Zinc and respiratory tract infections: Perspectives for COVID‑19 (Review).
Int J Mol Med. 2020 Jul;46(1):17-26. doi: 10.3892/ijmm.2020.4575. Epub 2020 Apr 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验